Thomas Moritz

3k citations
69 papers · 2.5k · h-index 26

Impact in

  • Immunology top 5%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
  • Hematology top 5%
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Chronic Myeloid Leukemia Treatments 7
    • Hematopoietic Stem Cell Transplantation 6
    • Virus-based gene therapy research 21
    • Blood disorders and treatments 3

Thomas Moritz

67 papers receiving 2.4k citations

Peers

Thomas Moritz
Comparison fields: 5 of 82
  • Immunology 473
  • Hematology 255
  • Genetics 137
  • Molecular Biology 876
  • Oncology 293
Replace Nico Lachmann with:
Nico Lachmann Germany
Lora W. Barsky United States
Yuji Kashiwakura Japan
Sabine Charrier France
Wendy Kay Nevala United States
Marion Kleijer Netherlands
Juergen L. Foell Germany
Yasuo Mori Japan
Sylvain Fisson France
Dorothee Wernet Germany
Thomas Moritz relative to Nico Lachmann Germany Nico Lachmann's profile →
Citations per field
00.5×1.6×
Nico Lachmann · 1×
Citations per year

Countries citing papers authored by Thomas Moritz

Since Specialization
Citations

This map shows the geographic impact of Thomas Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moritz more than expected).

Fields of papers citing papers by Thomas Moritz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moritz. The network helps show where Thomas Moritz may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Moritz Line = papers co-authored together Thomas Moritz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014261
2 2015179
3 2018137
4 2014100
5 198993
6 201390
7 202088
8 201182
9 201677
10 201372
11 201572
12 201562
13 202261
14 201859
15 202359
16 200957
17 200755
18 199153
19 199351
20 201346

About Thomas Moritz

Thomas Moritz is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Genetics, having authored 69 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), Pluripotent Stem Cells Research (21 papers), Chronic Myeloid Leukemia Treatments (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), T-cell and B-cell Immunology (5 papers), CRISPR and Genetic Engineering (4 papers) and Blood disorders and treatments (3 papers). The work is most often cited by research in Immunology (473 citations), Hematology (255 citations), Genetics (137 citations), Molecular Biology (876 citations) and Oncology (293 citations). Thomas Moritz has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Nico Lachmann, Axel Schambach, Mania Ackermann, Tobias Cantz, Gesine Hansen, Nils Pfaff, Sebastian Brennig, Takuji Suzuki, N. Niederle and Christine Happle. Their work appears in journals such as Gene Therapy, Stem Cell Reports, European Journal Of Haematology, Cancer Immunology Immunotherapy and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact